Full-Time

Bioengineer

Posted on 1/17/2025

Retro Biosciences

Retro Biosciences

51-200 employees

Develops therapeutics targeting aging mechanisms

Compensation Overview

$130k - $160kAnnually

Mid, Senior

San Carlos, CA, USA

The job is onsite.

Category
Computational Biology
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Machine Learning
Data Analysis
Requirements
  • Have a PhD degree (biology, bioengineering, or a related field) or MS with equivalent 3-6 years of intensive, relevant research experience. Industry experience is a plus.
  • Extensive experience with mammalian cell culture and molecular biology.
  • Experience with fluorescent microscopy and multicolor flow cytometry and cell sorting/enrichment.
  • Have strong analytical and problem-solving skills, coupled with excellent communication and organizational abilities to work efficiently and productively in a dynamic, scientifically rigorous, and fast-paced environment.
  • Have a burning desire to understand aging biology through the lens of modern data-rich measurement technologies.
Responsibilities
  • Contribute to a team of talented scientists with designing and conducting experiments to test AI/ML model predictions.
  • Contribute to the development and implementation of protocols for high-throughput/high content assays to feed into AI algorithms.
  • Analyze and communicate findings and progress to internal teams and collaborators as well as externally.
  • Collaborate with computational applied AI members as well as with other teams at Retro.
  • Stay abreast of latest developments in experimental biology and technological/methodological developments to continually enhance team capabilities and workflows.
Desired Qualifications
  • Have (co)-authored relevant publications.
  • Have experience with gene delivery and/or high-throughput screening library preparation.
  • Have demonstrated experience in design and execution of high content screens (CRISPRa/i/ko, ORF, etc).
  • Have demonstrated experience in bioinformatics analysis of transcriptomics/ epigenomics/ genomics data and familiarity with AI/ML concepts.

Retro Biosciences focuses on extending healthy human lifespan by developing therapeutics that target the cellular mechanisms of aging. The company operates in the biotechnology sector, addressing the root causes of age-related diseases to help prevent multiple health issues. Its products work by utilizing advanced technologies such as single-cell multi-omics and computational biology to analyze and develop treatments through three main programs: cellular reprogramming, plasma-inspired therapeutics, and autophagy. Unlike many competitors, Retro Biosciences emphasizes a diversified approach with a balanced pipeline of potential treatments at various development stages. The goal is to reduce healthcare costs associated with aging by providing effective solutions that can lead to healthier lives for individuals.

Company Size

51-200

Company Stage

Seed

Total Funding

$175.1M

Headquarters

Redwood City, California

Founded

2021

Simplify Jobs

Simplify's Take

What believers are saying

  • Retro Biosciences secured $1 billion in funding to extend human lifespan.
  • Partnership with Multiply Labs enhances cell therapy manufacturing efficiency.
  • Collaboration with OpenAI improves stem cell production through AI models.

What critics are saying

  • Ethical concerns over longevity research may lead to regulatory scrutiny.
  • AI development may outpace regulatory frameworks, posing compliance challenges.
  • Technical challenges in automated cell therapy manufacturing could delay timelines.

What makes Retro Biosciences unique

  • Retro Biosciences focuses on cellular reprogramming, autophagy, and plasma-inspired therapeutics.
  • The company aims to extend healthy human lifespan by ten years.
  • Retro Biosciences employs advanced technologies like single-cell multi-omics and computational biology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Paid Holidays

Parental Leave

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-1%

2 year growth

6%
Fortune
Jan 24th, 2025
Retro Biosciences Secures $1B for Longevity

Sam Altman is backing Retro Biosciences with a new funding round of $1 billion to extend human lifespan.

HK Silicon
Jan 23rd, 2025
Retro Biosciences to Raise $1B Funding

Retro Biosciences, a biotech company backed by OpenAI CEO Sam Altman, plans to raise $1 billion to fund its project aimed at extending human lifespan by 10 years. Altman initially provided $180 million in seed funding and will contribute more in the Series A round.

TechStory
Jan 18th, 2025
Experts Believe OpenAI's New AI Model Might Help in Extending Human Life

OpenAI has developed a specialized AI model, GPT-4b Micro, in collaboration with Retro Biosciences, a startup focused on extending human lifespan by ten years.

BD Pratidin
Jan 18th, 2025
OpenAI, Retro Biosciences working to extend 'human lifespan'

OpenAI, in partnership with longevity startup Retro Biosciences, has reportedly developed an artificial intelligence model aimed at enhancing the efficiency of stem cell production.

Longevity Technology
May 15th, 2024
Multiply Labs inks $85m deal with Retro Bio to automate cell therapy manufacturing

Longevity biotech Retro Biosciences has entered into an $85 million agreement with Multiply Labs to enhance the production of its cell therapies aimed at age-related diseases.

INACTIVE